CORCEPT THERAPEUTICS INC (CORT) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2017-12-31..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2017-12-31..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2017-12-31..
Borrowing debt
Overview →Financial period ending 2017-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2017-12-31. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2017-12-31. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2017-12-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 0.00 USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 0.00 USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | 88.74M USD | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Debt Securities, Available-for-sale, Current |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 220.54M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | (m) | (m) | $0.00 | $0.00 | (m) | $88.74M | $220.54M | (m) |
| 2017-09-30 | (m) | (m) | $0.00 | $0.00 | (m) | $75.16M | $110.67M | (m) |
| 2017-06-30 | (m) | (m) | $4.57M | $0.00 | (m) | $66.17M | $86.54M | (m) |
| 2017-03-31 | (m) | (m) | $10.11M | $0.00 | (m) | $52.77M | $75.34M | (m) |
| 2016-12-31 | (m) | (m) | $14.66M | $0.00 | (m) | (m) | $68.75M | (m) |
| 2016-09-30 | (m) | (m) | $18.73M | $0.00 | (m) | (m) | $62.93M | (m) |
| 2016-06-30 | (m) | (m) | $18.56M | $3.74M | (m) | (m) | $56.84M | (m) |
| 2016-03-31 | (m) | (m) | $16.32M | $8.72M | (m) | (m) | $52.91M | (m) |
| 2015-12-31 | (m) | (m) | $14.96M | $12.56M | (m) | (m) | $51.94M | (m) |
| 2015-09-30 | (m) | (m) | $13.51M | $16.13M | (m) | (m) | $48.38M | (m) |
| 2015-06-30 | (m) | (m) | $12.03M | $19.40M | (m) | (m) | $48.35M | (m) |
| 2015-03-31 | (m) | (m) | $10.66M | $22.13M | (m) | (m) | $48.22M | (m) |
| 2014-12-31 | (m) | (m) | $9.42M | $24.46M | (m) | (m) | $34.63M | (m) |
| 2014-09-30 | (m) | (m) | $8.66M | $25.99M | (m) | (m) | $37.16M | (m) |
| 2014-06-30 | (m) | (m) | $7.40M | $27.64M | (m) | (m) | $44.39M | (m) |
| 2014-03-31 | (m) | (m) | $6.90M | $28.22M | (m) | (m) | $52.83M | (m) |
| 2013-12-31 | (m) | (m) | $5.74M | $29.32M | (m) | (m) | $63.08M | (m) |
| 2013-09-30 | (m) | (m) | $4.50M | $30.14M | (m) | (m) | $71.06M | (m) |
| 2013-06-30 | (m) | (m) | $3.65M | $30.24M | (m) | (m) | $79.69M | (m) |
| 2013-03-31 | (m) | (m) | $3.90M | $28.89M | (m) | (m) | $88.14M | (m) |
| 2012-12-31 | (m) | (m) | $2.65M | $29.03M | (m) | (m) | $99.17M | (m) |
| 2012-09-30 | (m) | (m) | $2.25M | $28.32M | (m) | (m) | $105.52M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |